These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31090850)

  • 1. CASE SERIES OF PATIENTS UNDER BIWEEKLY TREATMENT WITH LARONIDASE: A REPORT OF A SINGLE CENTER EXPERIENCE.
    Kyosen SO; Toma L; Nader HB; Braga MC; Pereira VG; Canossa S; Pesquero JB; D'Almeida V; Martins AM
    Rev Paul Pediatr; 2019; 37(3):312-317. PubMed ID: 31090850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative laronidase dose regimen for patients with mucopolysaccharidosis I: a multinational, retrospective, chart review case series.
    Horovitz DD; Acosta AX; Giugliani R; Hlavatá A; Hlavatá K; Tchan MC; Lopes Barth A; Cardoso L; Embiruçu de Araújo Leão EK; Esposito AC; Kyosen SO; De Souza CF; Martins AM
    Orphanet J Rare Dis; 2016 Apr; 11(1):51. PubMed ID: 27129473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dose-optimization trial of laronidase (Aldurazyme) in patients with mucopolysaccharidosis I.
    Giugliani R; Rojas VM; Martins AM; Valadares ER; Clarke JT; Góes JE; Kakkis ED; Worden MA; Sidman M; Cox GF
    Mol Genet Metab; 2009 Jan; 96(1):13-9. PubMed ID: 19038563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme replacement therapy with laronidase (Aldurazyme(®)) for treating mucopolysaccharidosis type I.
    Jameson E; Jones S; Remmington T
    Cochrane Database Syst Rev; 2016 Apr; 4():CD009354. PubMed ID: 27033167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme replacement therapy with laronidase (Aldurazyme(®)) for treating mucopolysaccharidosis type I.
    Jameson E; Jones S; Wraith JE
    Cochrane Database Syst Rev; 2013 Nov; (11):CD009354. PubMed ID: 24257962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of laronidase therapy in patients with mucopolysaccharidosis type I who initiated enzyme replacement therapy in adult age. A systematic review and meta-analysis.
    Pérez-López J; Morales-Conejo M; López-Rodríguez M; Hermida-Ameijeiras Á; Moltó-Abad M
    Mol Genet Metab; 2017 Jun; 121(2):138-149. PubMed ID: 28410878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthropometric data of 14 patients with mucopolysaccharidosis I: retrospective analysis and efficacy of recombinant human alpha-L-iduronidase (laronidase).
    Tylki-Szymanska A; Rozdzynska A; Jurecka A; Marucha J; Czartoryska B
    Mol Genet Metab; 2010 Jan; 99(1):10-7. PubMed ID: 19783188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme replacement therapy with laronidase (Aldurazyme) for treating mucopolysaccharidosis type I.
    Jameson E; Jones S; Wraith JE
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009354. PubMed ID: 24085657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Long-Term Treatment with Laronidase in Patients with Mucopolysaccharidosis Type I.
    Laraway S; Mercer J; Jameson E; Ashworth J; Hensman P; Jones SA
    J Pediatr; 2016 Nov; 178():219-226.e1. PubMed ID: 27788836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome after three years of laronidase enzyme replacement therapy in a patient with Hurler syndrome.
    Thomas JA; Jacobs S; Kierstein J; Van Hove J
    J Inherit Metab Dis; 2006 Dec; 29(6):762. PubMed ID: 17089217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of recombinant human alpha-L-iduronidase (laronidase) on restricted range of motion of upper extremities in mucopolysaccharidosis type I patients.
    Tylki-Szymanska A; Marucha J; Jurecka A; Syczewska M; Czartoryska B
    J Inherit Metab Dis; 2010 Apr; 33(2):151-7. PubMed ID: 20217237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of anti-laronidase antibodies on efficacy and safety of laronidase enzyme replacement therapy for MPS I: A comprehensive meta-analysis of pooled data from multiple studies.
    Xue Y; Richards SM; Mahmood A; Cox GF
    Mol Genet Metab; 2016 Apr; 117(4):419-26. PubMed ID: 26920513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a Combination Therapy with Laronidase and Genistein in Treating Mucopolysaccharidosis Type I in a Mouse Model.
    Malinowska M; Nowicka W; Kloska A; Węgrzyn G; Jakóbkiewicz-Banecka J
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase).
    Wraith JE; Clarke LA; Beck M; Kolodny EH; Pastores GM; Muenzer J; Rapoport DM; Berger KI; Swiedler SJ; Kakkis ED; Braakman T; Chadbourne E; Walton-Bowen K; Cox GF
    J Pediatr; 2004 May; 144(5):581-8. PubMed ID: 15126990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I.
    Clarke LA; Wraith JE; Beck M; Kolodny EH; Pastores GM; Muenzer J; Rapoport DM; Berger KI; Sidman M; Kakkis ED; Cox GF
    Pediatrics; 2009 Jan; 123(1):229-40. PubMed ID: 19117887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early treatment with laronidase improves clinical outcomes in patients with attenuated MPS I: a retrospective case series analysis of nine sibships.
    Al-Sannaa NA; Bay L; Barbouth DS; Benhayoun Y; Goizet C; Guelbert N; Jones SA; Kyosen SO; Martins AM; Phornphutkul C; Reig C; Pleat R; Fallet S; Ivanovska Holder I
    Orphanet J Rare Dis; 2015 Oct; 10():131. PubMed ID: 26446585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laronidase.
    BioDrugs; 2002; 16(4):316-8. PubMed ID: 12196045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive eye pathology in mucopolysaccharidosis type I mice and effects of enzyme replacement therapy.
    Gonzalez EA; Visioli F; Pasqualim G; de Souza CFM; Marinho DR; Giugliani R; Matte U; Baldo G
    Clin Exp Ophthalmol; 2020 Apr; 48(3):334-342. PubMed ID: 31925897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful pregnancy and breastfeeding in a woman with mucopolysaccharidosis type I while receiving laronidase enzyme replacement. therapy.
    Castorina M; Antuzzi D; Richards SM; Cox GF; Xue Y
    Clin Exp Obstet Gynecol; 2015; 42(1):108-13. PubMed ID: 25864295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucopolysaccharidosis I under enzyme replacement therapy with laronidase--a mortality case with autopsy report.
    Lin HY; Lin SP; Chuang CK; Chen MR; Chen BF; Wraith JE
    J Inherit Metab Dis; 2005; 28(6):1146-8. PubMed ID: 16435211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.